Allergan Ignores Guidelines, Wins Award Anyway
I spent all day yesterday at the "DTC in the New Era" conference organized by my colleagues at DTC Perspectives, Inc. One of the most valuable things I came away with...
Interpretation of Ads: Hokey vs. Horny
Quoting a Wikipedia entry:"Dreams, in Freud's view, were all forms of 'wish-fulfillment' -- attempts by the unconscious to resolve a conflict of some sort, whether something recent or something from the...
CGC: Old Wine in New Bottles
If chatter and palaver of buzz marketing vendors at industry conferences is any gauge, pharmaceutical companies are very interested in consumer-generated content (CGC), which is touted as the next "new thing"...
Lipitor’s Jarvik: Fop or Flop?
Is Dr. Robert Jarvik, inventor of the Jarvik artificial heart, a fop? Or is he a flop?Dr. Jarvik appears in all the recent Lipitor ads such as the print ad shown...
Marketing 101: Newer is Better
I found this in a recent USA Today story:When it comes to prescription drugs, the Public Citizen Health Research Group advises consumers to follow the Seven-Year Rule: Unless there is no...
Product Web Sites Not Up to Par
Campbell-Ewald Health, a consultancy company, performed a proprietary "Digital Diagnosis" of 58 direct-to-consumer (DTC) pharmaceutical product Web sites and found them to be incomprehensible to 45% of the US population (see...
Print DTC, PhRMA Guidelines, and Balance
When the drug industry US trade association PhRMA released its Guiding Principles for Direct-to-Consumer (DTC) Advertising in 2005, it was thought that they would affect mostly television DTC ads. Many...
Free Lunch Redux
The recent post about the pharmaceutical industry "free lunch" program for physicians -- see "Free Lunch for Physicians: Newsweek Misleads" -- generated some feedback from members of the Pharma Marketing Online...
Snark Meter
In the course of writing this blog, I have come across many comments from people. Most -- I am happy to say -- are positive.One comment, however, referred to my post...
Pharma Support for CME Slows
2005 marks the third consecutive year of decreased growth in commercial support of continuing medical education (CME) by the pharmaceutical industry, according to the 2005 annual report of the Accreditation Council...
